Literature DB >> 12165090

Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections.

M-T Ekala1, H Jouin, F Lekoulou, O Mercereau-Puijalon, F Ntoumi.   

Abstract

Merozoite surface protein 2 (MSP2) expressed by Plasmodium falciparum asexual blood stages has been identified as a promising vaccine candidate. In order to explore allelic family-specific humoral responses which may be responsible for parasite neutralization during natural infections, isolates from individuals with either asymptomatic infections or uncomplicated malaria and residing in a Central African area where Plasmodium transmission is high and perennial, were analysed using MSP2 as polymorphic marker. The family-specific antibody responses were assessed by ELISA using MSP2 synthetic peptides. We observed an age-dependence of P. falciparum infection complexity. The decrease of infection complexity around 15 years of age was observed simultaneously with an increase in the mean number of MSP2 variants recognized. No significant difference in the P. falciparum genetic diversity and infection complexity was found in isolates from asymptomatic subjects and patients with uncomplicated malaria. The longitudinal follow-up showed a rapid development of immune responses to various regions of MSP2 variants within one week. Comparing humoral responses obtained with the other major antigen on the merozoite surface, MSP1, our findings suggest that different pathways of responsiveness are involved in antibody production to merozoite surface antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165090      PMCID: PMC1906438          DOI: 10.1046/j.1365-2249.2002.01904.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania.

Authors:  I Felger; A Irion; S Steiger; H P Beck
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

2.  Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study.

Authors:  A Färnert; A P Arez; H A Babiker; H P Beck; A Benito; A Björkman; M C Bruce; D J Conway; K P Day; L Henning; O Mercereau-Puijalon; L C Ranford-Cartwright; J M Rubio; G Snounou; D Walliker; J Zwetyenga; V E do Rosario
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.184

3.  Target antigens for asexual malaria vaccine development.

Authors:  R J Howard; B L Pasloske
Journal:  Parasitol Today       Date:  1993-10

4.  Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity.

Authors:  T Smith; H P Beck; A Kitua; S Mwankusye; I Felger; N Fraser-Hurt; A Irion; P Alonso; T Teuscher; M Tanner
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

5.  Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum.

Authors:  J D Chulay; J A Lyon; J D Haynes; A I Meierovics; C T Atkinson; M Aikawa
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

6.  Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.

Authors:  F al-Yaman; B Genton; R Anders; J Taraika; M Ginny; S Mellor; M P Alpers
Journal:  Parasite Immunol       Date:  1995-09       Impact factor: 2.280

7.  Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.

Authors:  C M Rzepczyk; P A Csurhes; R Lord; H Matile
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

Review 8.  Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization.

Authors:  A Bolad; K Berzins
Journal:  Scand J Immunol       Date:  2000-09       Impact factor: 3.487

9.  Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area.

Authors:  H Jouin; C Rogier; J F Trape; O Mercereau-Puijalon
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

10.  Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections.

Authors:  F Ntoumi; H Contamin; C Rogier; S Bonnefoy; J F Trape; O Mercereau-Puijalon
Journal:  Am J Trop Med Hyg       Date:  1995-01       Impact factor: 2.345

View more
  7 in total

Review 1.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.

Authors:  F H A Osier; L M Murungi; G Fegan; J Tuju; K K Tetteh; P C Bull; D J Conway; K Marsh
Journal:  Parasite Immunol       Date:  2010-03       Impact factor: 2.280

3.  Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.

Authors:  Christopher G Adda; Christopher A MacRaild; Linda Reiling; Kaye Wycherley; Michelle J Boyle; Vivian Kienzle; Paul Masendycz; Michael Foley; James G Beeson; Raymond S Norton; Robin F Anders
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

4.  Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.

Authors:  Josea Rono; Faith H A Osier; Daniel Olsson; Scott Montgomery; Leah Mhoja; Ingegerd Rooth; Kevin Marsh; Anna Färnert
Journal:  Clin Infect Dis       Date:  2013-08-27       Impact factor: 9.079

5.  Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens.

Authors:  Sreenivasulu B Reddy; Robin F Anders; Nadia Cross; Ivo Mueller; Nicolas Senn; Danielle I Stanisic; Peter M Siba; Mats Wahlgren; Fred Kironde; James G Beeson; Kristina E M Persson
Journal:  BMC Microbiol       Date:  2015-07-03       Impact factor: 3.605

6.  Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2.

Authors:  Christopher A MacRaild; Milan Zachrdla; Dean Andrew; Bankala Krishnarjuna; Jiří Nováček; Lukáš Žídek; Vladimír Sklenář; Jack S Richards; James G Beeson; Robin F Anders; Raymond S Norton
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

7.  Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.

Authors:  Bankala Krishnarjuna; Dean Andrew; Christopher A MacRaild; Rodrigo A V Morales; James G Beeson; Robin F Anders; Jack S Richards; Raymond S Norton
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.